» Articles » PMID: 27759094

Effectiveness Evaluation of Organized Screening for Esophageal Cancer: a Case-control Study in Linzhou City, China

Overview
Journal Sci Rep
Specialty Science
Date 2016 Oct 21
PMID 27759094
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

In China, esophageal cancer has remained a large burden, and endoscopic screening is expected to reduce esophageal cancer mortality. Therefore, a population-based case-control study was conducted to evaluate the effect of screening. Cases were defined as individuals who had died of esophageal cancer, and controls were residents from the same area (three per case) who had not died of esophageal cancer, matched by gender and birth year. The exposure status (whether cases and controls had ever attended the screening or not) was acquired by inspecting the well documented screening records. A conditional logistic regression model was used to estimate the odds ratios (OR) and their 95% confidence intervals (95% CI). There were 253 cases and 759 controls. The reduction in risk of esophageal cancer mortality in individuals who had ever attended screening was 47% (OR: 0.53, 95% CI: 0.37-0.77). Compared with never-screened subjects, the ORs for screened subjects within 36 and 48 months before the reference date were 0.59(0.39-0.89) and 0.59(0.40-0.87); the ORs for 50-59 year old subjects were 0.48(0.28-0.85). The results suggest a 47% reduction in esophageal cancer mortality risk due to endoscopic screening, which may have significant implications for esophageal cancer screening in China, especially in rural areas.

Citing Articles

Clinical and genetic characteristics of patients with TRG 0 and TRG III in esophageal squamous cell carcinoma after neoadjuvant therapy.

Song Y, Qi Y, Li F, Ding R, Liu T, You L Sci Rep. 2024; 14(1):17708.

PMID: 39085429 PMC: 11291696. DOI: 10.1038/s41598-024-68820-x.


Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma.

Zhao Y, Zhao H, Zhao M, Yu Y, Qi X, Wang J World J Gastroenterol. 2024; 30(20):2638-2656.

PMID: 38855150 PMC: 11154680. DOI: 10.3748/wjg.v30.i20.2638.


Time Trend of Upper Gastrointestinal Cancer Incidence in China from 1990 to 2019 and Analysis Using an Age-Period-Cohort Model.

Lin Y, Guo Z, Huang S, Ma J, Xiang Z, Huang Y Curr Oncol. 2022; 29(10):7470-7481.

PMID: 36290865 PMC: 9600964. DOI: 10.3390/curroncol29100588.


Subjective factors affecting prognosis of 469 patients with esophageal squamous cell carcinoma: a retrospective cohort study of endoscopic screening.

Nakamura J, Manabe N, Yamatsuji T, Fujiwara Y, Murao T, Ayaki M BMC Gastroenterol. 2022; 22(1):319.

PMID: 35764928 PMC: 9238142. DOI: 10.1186/s12876-022-02399-3.


Long-term results of an endoscopic screening program for superficial esophageal cancer in patients with head and neck squamous cell carcinoma.

Moura R, Kuboki Y, Baba E, Safatle-Ribeiro A, Martins B, de Paulo G Endosc Int Open. 2022; 10(2):E200-E208.

PMID: 35178338 PMC: 8847053. DOI: 10.1055/a-1675-2334.


References
1.
Wheeler J, Reed C . Epidemiology of esophageal cancer. Surg Clin North Am. 2012; 92(5):1077-87. DOI: 10.1016/j.suc.2012.07.008. View

2.
Wang G, Abnet C, Shen Q, Lewin K, Sun X, ROTH M . Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut. 2005; 54(2):187-92. PMC: 1774842. DOI: 10.1136/gut.2004.046631. View

3.
Mansour-Ghanaei F, Sokhanvar H, Joukar F, Shafaghi A, Yousefi-Mashhour M, Valeshabad A . Endoscopic findings in a mass screening program for gastric cancer in a high risk region - Guilan province of Iran. Asian Pac J Cancer Prev. 2012; 13(4):1407-12. DOI: 10.7314/apjcp.2012.13.4.1407. View

4.
Landy R, Pesola F, Castanon A, Sasieni P . Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study. Br J Cancer. 2016; 115(9):1140-1146. PMC: 5117785. DOI: 10.1038/bjc.2016.290. View

5.
Massat N, Dibden A, Parmar D, Cuzick J, Sasieni P, Duffy S . Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On. Cancer Epidemiol Biomarkers Prev. 2015; 25(3):455-62. DOI: 10.1158/1055-9965.EPI-15-0803. View